All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-39738001

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	39738001	G496S			COVID-19	G S L	View
2	39738001	P681R	S	S	COVID-19	G S L	View
3	39738001	N481K			COVID-19	G S L	View
4	39738001	P681H	S	S	COVID-19	G S L	View
5	39738001	N679K	S	S	COVID-19	G S L	View
6	39738001	F486P			COVID-19	G S L	View
7	39738001	F490S			COVID-19	G S L	View
8	39738001	A684V	S	S	COVID-19	S L	View
9	39738001	E484K	S	S	COVID-19	S L	View
10	39738001	G496A	S	S	COVID-19	S L	View
11	39738001	G496C	S	S	COVID-19	S L	View
12	39738001	G496R	S	S	COVID-19	S L	View
13	39738001	I692I	S	S	COVID-19	S L	View
14	39738001	Q677H	S	S	COVID-19	S L	View
15	39738001	S494P	S	S	COVID-19	S L	View
16	39738001	S496G	S	S	COVID-19	S L	View
17	39738001	S691S	S	S	COVID-19	S L	View
18	39738001	T478K	S	S	COVID-19	S L	View
19	39738001	F490L	RBD	S	COVID-19	S L	View
20	39738001	R493Q			COVID-19	S L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.